October 23, 2022
2 min watch
Save
VIDEO: Aerie gives update on dry eye, glaucoma clinical trials
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Michelle Senchyna, PhD, of Aerie Pharmaceuticals, provides an update on the company’s ongoing projects.
Senchyna discusses clinical studies investigating AR-15512 for the treatment of dry eye disease and Rocklatan (netarsudil 0.02% and latanoprost 0.005% ophthalmic solution) for the treatment of glaucoma.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Senchyna reports being the vice president of clinical development and medical affairs at Aerie.
Read more about